Pharmaceutical International News Archives - June 2011
Subscribe to SuppliersWeek 1 - June 2011
FDA Birth Control Drug Blood Clot Safety Study
Posted by Pharmaceutical International's Senior Journalist on 16:40:00
US drug regulator investigates whether a pair of birth control pills can be linked to an increased risk of blood clot development
Cancer Treatment Drugs Stop Heart Disease in Trials
Posted by Pharmaceutical International's Drug Development Correspondent on 14:25:00
HDAC inhibitor class drugs could have the potential to tackle and even reverse human heart disease, according to US trial results
No ARB Blood Pressure Treatment Drug Cancer Risk
Posted by Pharmaceutical International's Senior Journalist on 13:50:00
Angiotensin Receptor Blocker drugs cannot be linked to an elevated risk of cancer in patients taking them, according to the FDA
Week 2 - June 2011
Yervoy and Vemurafenib Excel in Skin Cancer Drug Trials
Posted by Pharmaceutical International's Senior Journalist on 14:45:00
New treatment drug pair could both be extremely valuable tools in the fight against skin cancer, which kills thousands each year
Epilepsy Drug Birth Defects Studied
Posted by Pharmaceutical International's Senior Journalist on 21:10:00
New study examining the dangers posed to babies by epilepsy drugs separates the safest treatments from the most risky
Bronchial Thermoplasty - New Asthma Treatment Approach
Posted by Pharmaceutical International's Senior Journalist on 16:15:00
New approach to asthma treatment now available in UK and could ultimately replace traditional drugs
Cancer Fears Cause French Actos Drug Ban
Posted by Pharmaceutical International's Senior Journalist on 15:45:00
French drug regulators have moved to ban diabetes treatment Actos over concerns that it could cause bladder cancer